Publications by authors named "Caputo R"

Tumor dissemination to the central nervous system (CNS) is almost a rule in the treatment journey of advanced HER2+ breast cancer (BC). Recent results demonstrated high intracranial efficacy with Trastuzumab Deruxtecan (T-DXd). However, a real-world evidence is lacking in literature.

View Article and Find Full Text PDF

Background: Estimating patient attrition across lines of treatment (i.e. the probability that upon treatment failure the patient will not be able to receive a subsequent treatment) may be a valuable tool for optimizing treatment sequencing.

View Article and Find Full Text PDF

Within the expanding therapeutic landscape for breast cancer (BC), metastatic breast cancer (MBC) remains virtually incurable and tend to develop resistance to conventional treatments ultimately leading to metastatic progression and death. Cellular immunotherapy (CI), particularly chimeric antigen receptor-engineered T (CAR-T) cells, has emerged as a promising approach for addressing this challenge. In the wake of their striking efficacy against hematological cancers, CAR-T cells have also been used where the clinical need is greatest - in patients with aggressive BCs.

View Article and Find Full Text PDF

Background: The Hormonal Bone Effects (HOBOE) study tested whether adjuvant triptorelin plus either letrozole (L) or zoledronic acid (Z) plus L (ZL) was more effective than tamoxifen (T) in premenopausal patients with hormone receptor-positive (HR+) early breast cancer (BC). Here we report the long-term follow-up analysis.

Patients And Methods: HOBOE (ClinicalTrials.

View Article and Find Full Text PDF

Purpose: A performance comparison of two myopia control spectacle lens designs, defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL), at slowing myopia progression in a European child/adolescent population. Previous research directly comparing these designs has been limited to Chinese participants and 1-year follow-up. The prevalence of myopia in European child/adolescent has been estimated at 22.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the effectiveness and safety of combining cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) with endocrine therapy (ET) in treating hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer, specifically comparing Asian and non-Asian patients.
  • A meta-analysis of 11 studies involving over 5,000 patients was conducted to analyze progression-free survival (PFS) and overall survival (OS) outcomes, as well as treatment-related adverse events.
  • Results showed that adding CDK4/6i to ET significantly improved both PFS and OS in both patient groups, indicating the treatment's effectiveness across diverse populations.
View Article and Find Full Text PDF

Thrombocytopenia is due to multifactorial causes in critically ill patients. One etiology is continuous renal replacement therapy (CRRT); however, it is unknown if different modalities impact the incidence. To compare the incidence of thrombocytopenia with the NxStage CRRT system using continuous venovenous hemodialysis (CVVHD) compared to the Prismaflex system using continuous venovenous hemodiafiltration (CVVHDF).

View Article and Find Full Text PDF

Data-driven material research for property prediction and material design using machine learning methods requires a large quantity, wide variety, and high-quality materials data. For battery materials, which are commonly polycrystalline, ceramics, and composites, multiscale data on substances, materials, and batteries are required. In this work, we develop a data network composed of three interlinked databases, from which we can obtain comprehensive data on substances such as crystal structures and electronic structures, data on materials such as chemical composition, structure, and properties, and data on batteries such as battery composition, operation conditions, and capacity.

View Article and Find Full Text PDF
Article Synopsis
  • Childhood chronic non-infectious uveitis (cNIU) is a complex condition that can mimic other diseases, like demyelinating disorders, and this study focuses on the brain MRI findings in affected children.
  • A total of 123 children with cNIU were analyzed, revealing that 26.8% exhibited white matter abnormalities (WMA), particularly among those with non-anterior uveitis and more frequently in males.
  • The study suggests that while brain MRIs might be beneficial for monitoring cNIU, the clinical implications of the observed WMAs remain unclear, highlighting the need for interdisciplinary assessment and further long-term studies.
View Article and Find Full Text PDF

The periodic number (PN) representation of the chemical systems, introduced by Dmitri Mendeleev, uncovers the fundamental principle of chemical similarity in a straightforward way. In this framework, the rows correspond to the principal quantum numbers of the elements' electronic configurations when considered isolated atoms. This systematic arrangement allows for a deeper understanding of the relationships and patterns among the elements.

View Article and Find Full Text PDF
Article Synopsis
  • Vernal keratoconjunctivitis (VKC) is a long-lasting eye disease that can affect children's vision and often gets worse in certain seasons.
  • A group of expert doctors in Italy worked together to create guidelines for diagnosing and treating VKC to help doctors manage the disease better.
  • They recommend getting diagnosed quickly, using specific tools like the Bonini score, and using short treatments for better results when needed.
View Article and Find Full Text PDF
Article Synopsis
  • * A total of 205 patients participated, with a 1-year target-vessel failure (TVF) rate of 7.4%, significantly below the performance goal set at 24.5%, and a 3-year TVF rate of 12.1%.
  • * The findings indicate that using a provisional stenting approach for bifurcation lesions with the Resolute Onyx ZES led to positive clinical outcomes, suggesting it
View Article and Find Full Text PDF

Abemaciclib demonstrated clinical benefit in women affected by HR+/HER2- advanced breast cancer (aBC). Drug-drug interactions (DDIs) can lead to reduced treatment efficacy or increased toxicity. This retro-prospective study aimed to evaluate outcomes, DDIs' impact, and toxicities of abemaciclib combined with endocrine therapy in a real-world setting.

View Article and Find Full Text PDF
Article Synopsis
  • The research focuses on developing new anticounterfeiting solutions using the physical unclonable function (PUF) concept.
  • A novel method combines electrospinning and electrospraying to create flexible films that contain various PUF keys for enhanced security.
  • These films allow for complex anticounterfeiting labels with multiple encryption levels, making them cost-effective and practical for protecting goods.
View Article and Find Full Text PDF
Article Synopsis
  • - The study focuses on examining the connection between genetic factors and observable traits in patients with grade I and II foveal hypoplasia who maintain stable vision and good visual acuity, utilizing advanced imaging techniques like OCT and AO.
  • - A total of eight patients aged 8 to 18 were assessed; key findings included an average best corrected visual acuity of 0.18 logMAR, normal photoreceptor counts, and abnormalities in OCT-A imaging, with some showing mild albinism and one diagnosed with Waardenburg syndrome.
  • - The results suggest that while photoreceptor numbers appear normal, the quality and distribution of these cells may be altered due to genetic variations, impacting their overall retinal structure and function.
View Article and Find Full Text PDF

Background: Intermediate clinical endpoints (ICEs) are frequently used as primary endpoint in randomised trials (RCTs). We aim to assess whether changes in different ICEs can be used to predict changes in overall survival (OS) in adjuvant breast cancer trials.

Methods: Individual patient level data from adjuvant phase III RCTs conducted by the Gruppo Italiano Mammella (GIM) and Mammella Intergruppo (MIG) study groups were used.

View Article and Find Full Text PDF

Objective: The objective of this multicenter, observational, retrospective analysis was to evaluate the safety and efficacy of sacituzumab govitecan in metastatic triple-negative breast cancer (mTNBC) patients managed according to common clinical practice in Italy.

Methods: Data were retrieved by 7 sites. Triple-negative BC was defined by the lack of expression of estrogen receptor (ER <1%), progesterone receptor (PgR <1%) and human-epidermal growth factor receptor-2 (HER2 0, 1+, 2+ ISH-not amplified) according to standard ASCO-CAP criteria.

View Article and Find Full Text PDF

Introduction: gene on 3p26-p25 encodes a protein involved in epigenetic regulation, through interaction with histone H3 lysine acetyltransferases KAT6A and KAT6B of the MYST family. Heterozygous pathogenic variants in gene are associated with Intellectual Developmental Disorder with Dysmorphic Facies and Ptosis (IDDDFP), characterized by global developmental delay, intellectual disability, language delay, and dysmorphic facial features. The reported ocular involvement includes strabismus, amblyopia, and refraction errors.

View Article and Find Full Text PDF
Article Synopsis
  • Recent improvements in breast cancer survival rates are not reflected for gender minorities, as they are often excluded from clinical trials.
  • A review of 51 phase III clinical trials showed that only 35.3% allowed men to enroll, and none reported on transgender or gender-diverse participants.
  • The study calls for more inclusive trial criteria to better represent gender minorities, highlighting a significant underrepresentation and varying enrollment rates across different drug classes.
View Article and Find Full Text PDF

A relevant percentage of breast cancers (BCs) are tied to pathogenetic (P)/likely pathogenetic (LP) variants in predisposing genes. The knowledge of P/LP variants is an essential element in the management of BC patients since the first diagnosis because it influences surgery and subsequent oncological treatments and follow-up. Moreover, patients with metastatic BCs can benefit from personalized treatment if carriers of P/LP in BRCA1/2 genes.

View Article and Find Full Text PDF

37.5% of deaths in our area occur in hospital. There are known high unmet needs of adult patients dying in hospital, this unmet need can be reduced by using an individualised care plan and specialist palliative care review.

View Article and Find Full Text PDF

Obesity and metabolic disorders have been associated with poor outcomes in non-Mediterranean breast cancer (BC) patients. The purpose of this study was to investigate the prognostic potential of anthropometric variables in patients with early BC living in Southern Mediterranean region of Italy. We enrolled 955 consecutive early BC patients treated in hospitals in Naples between 2009 and 2013 (median follow-up 11.

View Article and Find Full Text PDF
Article Synopsis
  • T-DXd showed high efficacy and safety in a real-world study of 143 HER2+ metastatic breast cancer patients in Italy, with a median progression-free survival (rwPFS) of 16 months.
  • Among patients with measurable disease, an overall response rate (ORR) of 68% and disease control rate (DCR) of 93% were observed, with some patients responding better when T-DXd was given earlier in the treatment line.
  • Common side effects included nausea and neutropenia, with 59% of patients experiencing any toxicity, but these adverse events did not significantly impact the patients' treatment response and survival outcomes.
View Article and Find Full Text PDF